Cysview, a tool designed to detect tiny bladder cancer tumors, has been shown to reduce bladder cancer recurrence by roughly 20%, according to urologist Dr. Stephen Jones. The device, which gained FDA approval last year, makes use of dye and fluorescent light to spot bladder cancer cells that are undetectable using standard lights.

Full Story:
KUSA-TV (Denver)

Related Summaries